Covira Builds Team, Closes First Dilutive Funding, Establishes Key Partnerships, and Prepares for Next Round of Funding

-The biotech Company’s proprietary technology generated a lead asset that modulates bacterial virulence and restores microbial communities to prevent post-surgical infections- CHICAGO, Oct. 6, 2022 /PRNewswire/ — Covira, a Chicago-area based microbiome-focused biotech company focused on…

About the Author

has written 41552 stories on this site.

Copyright © 2010 Business and Corporate News.